Ectopic Pregnancy
A pregnancy where the fertilized egg implants outside the uterus, most commonly in the fallopian tube, posing a life-threatening risk of rupture and internal bleeding.
Emergency Management: Ruptured ectopic pregnancy presenting with hemorrhagic shock (hypotension, tachycardia, altered mental status). Requires immediate fluid resuscitation, blood transfusion (O-negative if crossmatch not ready), and emergent surgical exploration (laparoscopy or laparotomy) to achieve hemostasis.
An ectopic pregnancy occurs when a fertilized ovum implants outside the normal uterine cavity. Approximately 90-95% implant in the fallopian tube (most commonly the ampulla). It is an obstetric emergency, as rupture of the ectopic gestation can lead to catastrophic internal hemorrhage and maternal death.
Detailed Overview
Normal embryo transport through the fallopian tube is hindered due to functional or structural tubal abnormalities, often secondary to prior inflammation or surgery. The trophoblast invades the tubal wall, which lacks the thick decidual lining of the uterus. As the embryo grows, it stretches the thin tubal wall. The highly vascular tubal mucosa is compromised, leading to luminal bleeding, or the expanding sac causes tubal rupture, resulting in massive hemoperitoneum. This condition is the leading cause of maternal mortality in the first trimester.
Epidemiology & Demographics
Accounts for about 1.5-2.0% of all reported pregnancies. The incidence has increased slightly over the past decades, largely due to better diagnostics, rising maternal age, and increased prevalence of pelvic inflammatory disease (PID) and assisted reproductive technology (ART).
Etiological Mechanism
The primary etiology is altered tubal transport mechanisms. Damage to the ciliated epithelium of the fallopian tube prevents the fertilized egg from reaching the uterus, leading to premature implantation in the tubal wall.
Primary Causes
Pelvic Inflammatory Disease (Chlamydia trachomatis, Neisseria gonorrhoeae)
Prior Tubal Surgery (e.g., tubal ligation or reconstruction)
Endometriosis
Congenital Tubal Anomalies
Impaired transport allows the blastocyst to hatch and implant in the fallopian tube wall. The invading syncytiotrophoblast erodes into maternal blood vessels. Unlike the uterus, the fallopian tube muscularis is too thin to accommodate the growing conceptus or the ensuing hemorrhage. Hemorrhage occurs between the gestational sac and the tubal wall, causing dissection. This can lead to tubal abortion (extrusion out the fimbriated end) or frank tubal rupture. Rupture releases blood rapidly into the peritoneal cavity, leading to shock.
Diagnostic Criteria & Guidelines
A positive serum quantitative beta-hCG plus transvaginal ultrasound showing an adnexal mass/empty uterus. If beta-hCG is above the discriminatory zone (typically >1,500 to 3,500 mIU/mL depending on the institution) and ultrasound shows an empty uterus, it is highly suspicious for ectopic pregnancy. Serial beta-hCG levels that fail to rise appropriately (at least 35-53% in 48 hours) also suggest abnormal pregnancy.
For hemodynamically stable patients with unruptured ectopic < 3.5-4.0 cm, no fetal heartbeat, and beta-hCG < 5,000 mIU/mL: Methotrexate 50 mg/m² intramuscularly (single-dose protocol). Monitor beta-hCG on days 4 and 7; require a 15% drop between days 4 and 7.
Second-Line & Adjunctive Therapy
If Methotrexate fails (beta-hCG does not fall by >15% between days 4 and 7), a second dose of Methotrexate (50 mg/m² IM) may be administered, or surgical intervention is pursued.
Surgical & Procedural Management
Laparoscopic Salpingostomy (removing the ectopic tissue and preserving the tube) or Salpingectomy (removal of the affected tube). Salpingectomy is preferred if the tube is extensively damaged, the patient is hemodynamically unstable, or fertility is no longer desired. Emergent laparotomy is indicated for severe hemorrhagic shock.
Patient Counseling & Advice
Inform the patient that an ectopic pregnancy cannot result in a live birth and carries a life-threatening risk if untreated. Advise that future pregnancies are possible, but there is a 10-15% recurrence risk. Any future pregnancy requires early TVUS (at 5-6 weeks) to confirm intrauterine location.
Follow-Up & Monitoring Schedule
If managed with Methotrexate, weekly serum beta-hCG draws are required until levels reach non-pregnant values (<5 mIU/mL). This can take up to 8 weeks. Administer Rh(D) immune globulin (e.g., RhoGAM 300 mcg IM) to Rh-negative, unsensitized women.
Preventive Strategies
Prompt diagnosis and treatment of STIs (chlamydia, gonorrhea) to prevent PID. Use of condoms reduces STI transmission.
With prompt diagnosis, maternal mortality is extremely rare (<0.1%). Successful treatment with Methotrexate occurs in 70-90% of appropriately selected cases. Subsequent intrauterine pregnancy rates are generally 50-80%.